Skip to content
HARVARD.EDU
Diversity, Equity and Inclusion (DEI) Steering Committee
Educational Opportunities
Harvard University Center for AIDS Research
About
About the HU CFAR
Team
Acknowledging the CFAR
Contact Us
Stay Connected with HU CFAR
Executive Committee
Eligibility & Membership
External Scientific Advisory Board
Core Services
Core Services Overview
Administrative Core
Advanced Lab Technologies Core
Bio-behavioral and Community Science Core
Biostatistics and Bioinformatics Core
Clinical Core
Developmental and Mentoring Core
Research & Programs
Research & Programs Overview
Substance Use and HIV
Hepatitis and HIV
HIV and Malignancy
Inter-CFAR Antiretrovirals for Prevention Working Group
Inter-CFAR Collaboration on HIV Research in Women Working Group
Program in Adolescence and HIV
Program in Placental and HIV
Program in HIV Vaccines
Program in HIV Eradication
Program in Health Economics and Modeling
Diversity, Equity and Inclusion (DEI) Steering Committee
Basic & Translational Science Steering Committee (BTS-SC)
Ending the HIV Epidemic (EHE) Steering Committee
Community Engaged Research Program (CERP)
Funding
Funding Overview
Developmental & Mentoring Core Request for Proposals
NIH Administrative Supplements
NIH CFAR Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI) Supplement
NIH Ending the HIV Epidemic (EHE) Supplements
Additional NIH Funding
Mentoring & Training
Mentoring & Training Overview
Research in Progress Meetings
First Wednesdays
HOPE Conference
K Workshop
Mock K Review
Mentoring the Mentors
T32 Training Program
Outreach and Mentoring Opportunities
News & Events
News
Calendar
Past Events
Educational Opportunities
Job Opportunities
Search
Toggle search interface
Menu
Toggle extended navigation
Home
2024
June
26
NIH Statement on Preliminary Efficacy Results of Twice-Yearly Lenacapavir for HIV Prevention in Cisgender Women
NIH Statement on Preliminary Efficacy Results of Twice-Yearly Lenacapavir for HIV Prevention in Cisgender Women
READ/DOWNLOAD THE NEWS RELEASE BELOW:
NIH-Statement-on-Preliminary-Efficacy-R
Download
Post navigation
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Coordinating Center Infrastructure to Support Research on Opioid Overdose and HIV Risk in the Context of Justice Systems
NIAID June 2024: Council-Approved Concepts
close menu
About
About the HU CFAR
Team
Acknowledging the CFAR
Contact Us
Stay Connected with HU CFAR
Executive Committee
Eligibility & Membership
External Scientific Advisory Board
Core Services
Core Services Overview
Administrative Core
Advanced Lab Technologies Core
Bio-behavioral and Community Science Core
Implementation Science Resources
Useful implementation science articles
Implementation Science resources for HU CFAR members
Biostatistics and Bioinformatics Core
Clinical Core
Developmental and Mentoring Core
Research & Programs
Research & Programs Overview
Substance Use and HIV
Hepatitis and HIV
HIV and Malignancy
Inter-CFAR Antiretrovirals for Prevention Working Group
Inter-CFAR Collaboration on HIV Research in Women Working Group
Program in Adolescence and HIV
Program in Placental and HIV
Program in HIV Vaccines
Program in HIV Eradication
Program in Health Economics and Modeling
Diversity, Equity and Inclusion (DEI) Steering Committee
Basic & Translational Science Steering Committee (BTS-SC)
Ending the HIV Epidemic (EHE) Steering Committee
Community Engaged Research Program (CERP)
Funding
Funding Overview
Developmental & Mentoring Core Request for Proposals
NIH Administrative Supplements
NIH CFAR Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI) Supplement
NIH Ending the HIV Epidemic (EHE) Supplements
Additional NIH Funding
Mentoring & Training
Mentoring & Training Overview
Research in Progress Meetings
First Wednesdays
HOPE Conference
K Workshop
Mock K Review
Mentoring the Mentors
T32 Training Program
Outreach and Mentoring Opportunities
News & Events
News
Calendar
Past Events
Educational Opportunities
Job Opportunities
close search
Search
Search Site
